Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.66 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.66 |
| ▸ | HTR3B | O95264 | 1/20 | 0.66 |
| ▸ | HTR3A | P46098 | 1/20 | 0.66 |
| ▸ | BACE1 | P56817 | 1/20 | 0.66 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.66 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 8/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.63 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.63 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 8/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | GAA | P10253 | 5/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | GLA | P06280 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.61 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6621844 | 0.98 | PLAU (0.63) | PLAUHTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL29449363 | 0.83 | MEN1 (0.57) | PLAUHTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL118057 | 0.83 | MEN1 (0.57) | PLAUHTR3EHTR3BHTR3ABACE1 | |
| Hydrochloric Acid SCHEMBL6621838 | 0.81 | MEN1 (0.55) | PLAUHTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL28241210 | 0.80 | PLAU (0.57) | PLAUHTR3EHTR3BHTR3ABACE1 | |
| SCHEMBL3035650 | 0.79 | MEN1 (0.59) | PLAUMEN1KMT2ARXFP1CACNA1B | |
| SCHEMBL30147103 | 0.79 | MEN1 (0.59) | MEN1KMT2ARXFP1CACNA1BAPBA1 | |
| SCHEMBL1925827 | 0.79 | MAPT (0.76) | MEN1KMT2ARXFP1CACNA1BAPBA1 | |
| SCHEMBL172884 | 0.79 | MEN1 (0.59) | MEN1KMT2ARXFP1CACNA1BAPBA1 | |
| SCHEMBL1663312 | 0.79 | MAPT (0.60) | HTR3EHTR3BHTR3ABACE1HTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109709-A1 | 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS | MIRATI THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| WO-2025085329-A1 | MULTIFUNCTIONAL ADHESION PROMOTER FOR SEMICONDUCTOR DEVICE PACKAGES | WOLFSPEED, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| US-20250122413-A1 | Multifunctional Adhesion Promoter for Semiconductor Device Packages | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2025-04-17 | — | — | US | claimed |
| CN-114976047-B | Catalyst for electro-oxidation of methanol and preparation method thereof | 南京大学 | 2024-08-23 | — | — | CN | claimed |
| CN-114976047-A | Catalyst for methanol electrooxidation and preparation method thereof | 南京大学 | 2022-08-30 | — | — | CN | claimed |
| CN-112426884-A | Antibacterial composite reverse osmosis membrane and preparation method thereof | 嘉兴市爵拓科技有限公司 | 2021-03-02 | — | — | CN | claimed |
| EP-3105210-A1 | BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2016-12-21 | — | — | EP | claimed |
| WO-2015121209-A1 | BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-08-20 | — | — | WO | claimed |
| EP-1576093-A4 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS INC (US) | 2009-07-08 | — | — | EP | claimed |
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | DYNAMIS THERAPEUTICS, INC. | 2007-03-22 | — | — | US | claimed |
| EP-1753861-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | Dynamis Therapeutics, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1576093-A2 | 3-DEOXYGLUCOSONE AND SKIN | Dynamis Therapeutics, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| WO-2005079463-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | DYNAMIS THERAPEUTICS, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | DYNAMIS THERAPEUTICS, INC. | 2005-07-21 | — | — | US | claimed |
| WO-2005007083-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| WO-2003089601-A2 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-4321363-A | Adsorbent for urokinase containing agarose | NIPPON SODA COMPANY LIMITED (JP) | 1982-03-23 | — | — | US | claimed |
| WO-2025085329-A1 | MULTIFUNCTIONAL ADHESION PROMOTER FOR SEMICONDUCTOR DEVICE PACKAGES | WOLFSPEED, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-4321363-A | Adsorbent for urokinase containing agarose | NIPPON SODA COMPANY LIMITED (JP) | 1982-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070065443-A1 | Fructoseamine 3 kinase and the formation of collagen and elastin | FN3K, PDXK, COLGALT1 | PLAU 913/4885HTR3E 2038/4885HTR3B 1868/4885 |
| US-20260109709-A1 | 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS | PRMT5, PRMT1, PRMT3 | PLAU 4162/4885HTR3E 3497/4885HTR3B 3914/4885 |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DPM1, G6PD, UGGT1 | PLAU 1729/4885HTR3E 3243/4885HTR3B 2453/4885 |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | AGER, GLA, GALE | PLAU 1583/4885HTR3E 1522/4885HTR3B 2772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.